Rifaximin Treatment of Papulopustular Rosacea

NCT01359228 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Rosacea

Interventions

DRUG: Rifaximin (XIFAXAN)
DRUG: Placebo

Sponsor

University of California, San Francisco